Ternary herbicidal combination comprising saflufenacil

Abstract

The present invention relates to a herbicidal combination which comprises: a) a herbicide A which is 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl-(1-methylethyl)-amino]sulfonyl]benzamide, b) a single herbicide B selected from sulfentrazone, flumioxazin, dicamba and their salts and esters, and c) at least one herbicide C different from herbicides A and B which is selected from C.1) herbicides of the group of acetolactate synthase inhibitors, C.2) herbicides of the group of protoporphyrinogen oxidase inhibitors, C.3) herbicides of the group of synthetic auxins, C.4) herbicides of the group of microtubule inhibitors, C.5) herbicides of the group of acetyl-CoA carboxylase inhibitors, C.6) herbicides of the group of photosystem II inhibitors, C.7) herbicides of the group of pigment synthesis inhibitors, and C.8) herbicides of the group of VLCFA inhibitors selected from chloroacetamide herbicides, oxyacetamide herbicides, acetamide herbicides and tetrazolinone herbicides; provided that the herbicidal combination does not include pyroxasulfone; provided that in case the components b) or c) comprise dicamba or one of its salts or esters the herbicidal combination does not include imazapyr or one of its salts; and provided that if component b) is flumioxazin and component c) is 2,4-D, 2,4-D is present as its 2-ethylhexyl ester.

Claims

1. A herbicidal composition comprising a) a herbicide A which is 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl-(1-methylethyl)-amino]sulfonyl]benzamide, b) a single herbicide B selected from the group consisting of sulfentrazone, flumioxazin, dicamba and their salts and esters, and c) at least one herbicide C different from herbicides A and B which is selected from the group consisting of fomesafen, dimethenamid, acetochlor, pendimethalin, dicamba, imazamox, imazethapyr, atrazine, diclosulam, mesotrione, isoxaflutole, topramezone, clethodim, 2,4-D, and their agriculturally acceptable enantiomers, salts and esters, wherein the weight ratio of B to A is 35:1 to 1:5; the weight ratio of A to C is 1:75 to 10:1 and the weight ratio of B to the sum of A and C is 30:1 to 1:60; provided that the herbicidal composition does not include pyroxasulfone, metolachlor, or s-metolachlor; provided that in case the components b) or c) comprise dicamba or one of its salts or esters the herbicidal composition does not include imazapyr or one of its salts; and provided that if component b) is flumioxazin, component c) is not 2,4-D or its salt or ester.

2. The herbicidal composition of claim 1, wherein the at least one herbicide C is diclosulam, imazamox or imazethapyr, or their agriculturally acceptable salts or esters.

3. The herbicidal composition of claim 1, wherein the at least one herbicide C is fomesafen or its agriculturally acceptable salt or ester.

4. The herbicidal composition of claim 1, wherein the at least one herbicide C is dicamba or 2,4-D, or their agriculturally acceptable salts or esters.

5. The herbicidal composition claim 1, wherein the at least one herbicide C is pendimethalin.

6. The herbicidal composition of claim 1, wherein the at least one herbicide C is atrazine or its agriculturally acceptable salt.

7. The herbicidal composition of claim 1, wherein the at least one herbicide C is mesotrione or topramezone or their agriculturally acceptable salts.

8. The herbicidal composition of claim 1, wherein the at least one herbicide C is dimethenamid or acetochlor or their agriculturally acceptable enantiomers.

9. The herbicidal composition of claim 1, wherein the herbicide B is sulfentrazone.

10. The herbicidal composition of claim 1, wherein the herbicide B is flumioxazin.

11. The herbicidal composition of claim 1, wherein the herbicide B is selected from the group consisting of dicamba and its agriculturally acceptable salts and esters.

12. A method for controlling undesirable vegetation, which method comprises applying the herbicidal composition of claim 1 to a locus where undesirable vegetation is present or is expected to be present.

13. A method for burn-down treatment of undesirable vegetation in crops, comprising applying the herbicidal composition of claim 1 to a locus where crops will be planted before planting or emergence of the crop.

14. A herbicidal composition comprising a) a herbicide A which is 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl-(1-methylethyl)-amino]sulfonyl]benzamide, b) a single herbicide B selected from the group consisting of sulfentrazone, flumioxazin, dicamba and their salts and esters, and c) at least one herbicide C different from herbicides A and B which is selected from the group consisting of fomesafen, dimethenamid, acetochlor, pendimethalin, dicamba, imazamox, imazethapyr, atrazine, diclosulam, mesotrione, isoxaflutole, topramezone, clethodim, 2,4-D, and their agriculturally acceptable enantiomers, salts and esters, wherein: the weight ratio of B to A is 35:1 to 1:5; the weight ratio of A to C is 1:75 to 10:1 and the weight ratio of B to the sum of A and C is 30:1 to 1:60; provided that the herbicidal composition does not include pyroxasulfone; provided that in case the components b) or c) is dicamba or one of its salts or esters the herbicidal composition does not include imazapyr or one of its salts; provided that if the component b) is flumioxazin, component c) is not 2,4-D or its salt or ester; and provided that in case the component b) is flumioxazin, component c) is not fomesafen or its salt.

15. The herbicidal composition of claim 14, wherein the herbicide B is sulfentrazone.

16. The herbicidal composition of claim 14, wherein the herbicide B is flumioxazin.

17. The herbicidal composition of claim 14, wherein the herbicide B is selected from the group consisting of dicamba and its agriculturally acceptable salts and esters.

Description

USE EXAMPLES

(1) The effect of the herbicidal combinations according to the invention of herbicides A, B and C and, if appropriate, safener on the growth of undesirable plants compared to the herbicidally active compounds alone or binary mixtures thereof was demonstrated by the following greenhouse experiments:

(2) The test plants were first grown to a height of 3 to 20 cm, depending on the plant habit, and only then treated (post-emergence treatment). Here, the herbicidal combinations were suspended, emulsified or dissolved in water as distribution medium and afterwards applied by spraying, using finely distributing nozzles.

(3) The herbicides A, B and C were used as commercially available formulations and introduced to the spray liquor with the amount of solvent system used for applying the active compound. In the examples, the solvent used was water.

(4) Saflufenacil was used as a commercially available suspension concentrate having an active ingredient concentration of 340 g/l.

(5) Sulfentrazone was used as a commercially available suspension concentrate having an active ingredient concentration of 480 g/l.

(6) Flumioxazin was used as a commercially available WG-formulation having an active ingredient concentration of 50% by weight.

(7) Dimethenamid-P was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 720 g/l.

(8) Acetochlor was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 840 g/l.

(9) Pendimethalin was used as a commercially available aqueous capsule suspension having an active ingredient concentration of 455 g/l.

(10) Dicamba was used as a commercially available SL-formulation having an active ingredient concentration of 480 g/l.

(11) Atrazine was used as a commercially available WG-formulation having an active ingredient concentration of 84% by weight.

(12) Mesotrione was used as a commercially available suspension concentrate having an active ingredient concentration of 480 g/l.

(13) Diclosulam was used as a commercially available WG-formulation having an active ingredient concentration of 84% by weight.

(14) Isoxaflutole was used as a commercially available suspension concentrate having an active ingredient concentration of 240 g/l.

(15) 2,4-D was used as a commercially available emulsifiable concentrate containing 660 g/l of 2,4,D in the form of its 2-ethylhexyl ester (also named low volatile (LV) ester).

(16) Imazamox was used as a commercially available SL-formulation having an active ingredient concentration of 120 g/l.

(17) Imazethapyr was used as a commercially available SL-formulation having an active ingredient concentration of 240 g/l.

(18) Topramezone was used as a commercially available suspension concentrate having an active ingredient concentration of 336 g/l.

(19) Fomesafen was used as a commercially available microemulsion having an active ingredient concentration of 225 g/l.

(20) Clethodim was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 240 g/l.

(21) The test period extended over 20 days. During this time, the plants were tended, and their response to the treatments with active compounds was evaluated.

(22) The evaluation for the damage caused by the chemical compositions was carried out using a scale from 0 to 100%, compared to the untreated control plants. Here, 0 means no damage and 100 means complete destruction of the plants.

(23) The plants used in the greenhouse experiments belonged to the following species:

(24) TABLE-US-00003 Scientific Name Code Common Name Abutilon theophrasti ABUTH velvetleaf Amaranthus retroflexus AMARE pig weed Avena fatua AVEFA wild oat Brachiaria decumbens BRADC Surinam grass Brachiaria platyphylla BRAPP broadleaf signalgrass Digitaria sanguinalis DIGSA large crabgrass Echinochloa crus-galli ECHCG barnyardgrass Setaria viridis SETVI green foxtail Solarium nigrum SOLNI black nightshade

(25) Colby's formula was applied to determine whether the composition showed synergistic action. The value E, which is to be expected if the activity of the individual compounds is just additive, was calculated using the method of S. R. Colby (1967) Calculating synergistic and antagonistic responses of herbicide combinations, Weeds 15, p. 22 ff. For two component mixtures the value E was calculated by the following formula
E=X+Y(X.Math.Y/100)

(26) where X=effect in percent using a mixture of herbicides A and B at application rates a and b, respectively; Y=effect in percent using herbicide C at an application rate c; E=expected effect (in %) of A+B+C at application rates a+b+c.

(27) If the value observed in this manner is higher than the value E calculated according to Colby, a synergistic effect is present.

(28) Tables 1 to 41 relate to the herbicidal activities of the binary mixture of herbicides A and B, of herbicide C individually and of their combinations in post-emergence applications assessed 20 days after treatment (20 DAT).

(29) TABLE-US-00004 TABLE 1 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Flumioxazin binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + flumioxazin sulfentrazone (B) flumioxazin (C) Synergism A B % activity % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 1.5 30 0.5 40 0.25 + 1.5 + 0.5 65 58 Y

(30) TABLE-US-00005 TABLE 2 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Dimethenamid-P binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + dimethenamid-P sulfentrazone (B) dimethenamid-P (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.125 0.75 70 18.75 0 0.125 + 0.75 + 18.75 100 70 Y AVEFA 0.5 1.5 40 75.0 20 0.5 + 1.5 + 75.0 60 52 Y

(31) TABLE-US-00006 TABLE 3 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Acetochlor binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + acetochlor sulfentrazone (B) acetochlor (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.125 0.75 70 12.5 0 0.125 + 0.75 + 12.5 100 70 Y SETVI 0.25 1.5 30 50.0 10 0.25 + 1.5 + 50.0 50 37 Y

(32) TABLE-US-00007 TABLE 4 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Pendimethalin binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + pendimethalin sulfentrazone (B) pendimethalin (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.125 0.75 35 37.5 0 0.125 + 0.75 + 37.5 75 35 Y ECHCG 0.25 1.5 30 150.0 0 0.25 + 1.5 + 150.0 50 30 Y

(33) TABLE-US-00008 TABLE 5 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Dicamba binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + dicamba sulfentrazone (B) dicamba (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.125 0.75 35 4.375 40 0.125 + 0.75 + 4.375 80 61 Y BRAPP 0.25 1.5 10 17.5 40 0.25 + 1.5 + 17.5 60 46 Y

(34) TABLE-US-00009 TABLE 6 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Atrazine binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + atrazine sulfentrazone (B) atrazine (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.125 0.75 35 12.5 55 0.125 + 0.75 + 12.5 75 71 Y AVEFA 0.25 1.5 20 12.5 0 0.25 + 1.5 + 12.5 35 20 Y

(35) TABLE-US-00010 TABLE 7 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Diclosulam binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + diclosulam sulfentrazone (B) diclosulam (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 1.5 20 0.5 25 0.5 + 1.5 + 0.5 45 40 Y SOLNI 0.25 0.75 60 0.125 0 0.25 + 0.75 + 0.125 75 60 Y

(36) TABLE-US-00011 TABLE 8 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Mesotrione binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + mesotrione sulfentrazone (B) mesotrione (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 1.5 20 2.5 80 0.5 + 1.5 + 2.5 95 84 Y

(37) TABLE-US-00012 TABLE 9 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Isoxaflutole binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + isoxaflutole sulfentrazone (B) isoxaflutole (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 1.5 20 1.0 25 0.5 + 1.5 + 1.0 55 40 Y SOLNI 0.25 0.75 60 0.5 70 0.25 + 0.75 + 0.5 98 88 Y

(38) TABLE-US-00013 TABLE 10 Application in Post-Emergence of Saflufenacil, Sulfentrazone and 2-ethylhexyl ester of 2,4-D (here: 2,4-D LV ester) binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + 2,4-D LV ester sulfentrazone (B) 2,4-D LV ester (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 1.5 20 6.25 0 0.5 + 1.5 + 6.25 65 20 Y

(39) TABLE-US-00014 TABLE 11 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Imazamox binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + sulfentrazone + imazamox sulfentrazone (B) imazamox (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.5 1.5 60 0.5 15 0.5 + 1.5 + 0.5 80 66 Y DIGSA 0.5 1.5 25 1.0 15 0.5 + 1.5 + 1.0 50 36 Y AMARE 0.5 1.5 80 0.5 40 0.5 + 1.5 + 0.5 100 88 Y ABUTH 0.5 1.5 60 0.5 0 0.5 + 1.5 + 0.5 70 60 Y

(40) TABLE-US-00015 TABLE 12 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Topramezone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + sulfentrazone + topramezone sulfentrazone (B) topramezone (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.5 1.5 60 0.25 0 0.5 + 1.5 + 0.25 70 60 Y ECHCG 0.25 1.5 45 0.25 25 0.25 + 1.5 + 0.25 65 59 Y BRADC 0.25 1.5 0 0.5 0 0.25 + 1.5 + 0.5 25 0 Y AMARE 0.5 1.5 80 0.25 40 0.5 + 1.5 + 0.25 100 88 Y ABUTH 0.25 1.5 55 0.25 10 0.25 + 1.5 + 0.25 80 60 Y

(41) TABLE-US-00016 TABLE 13 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Imazethapyr binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + sulfentrazone + imazethapyr sulfentrazone (B) imazethapyr (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 1.5 25 0.5 15 0.5 + 1.5 + 0.5 65 36 Y AVEFA 0.5 1.5 10 0.5 0 0.5 + 1.5 + 0.5 20 10 Y AMARE 0.5 1.5 80 1.0 55 0.5 + 1.5 + 1.0 100 91 Y

(42) TABLE-US-00017 TABLE 14 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Fomesafen binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + sulfentrazone + fomesafen sulfentrazone (B) fomesafen (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 3.0 80 1.5 5 0.5 + 3.0 + 1.5 100 81 Y

(43) TABLE-US-00018 TABLE 15 Application in Post-Emergence of Saflufenacil, Sulfentrazone and Clethodim binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + sulfentrazone + clethodim sulfentrazone (B) clethodim (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 3.0 80 0.75 5 0.5 + 3.0 + 0.75 100 81 Y AVEFA 0.5 3.0 30 0.75 20 0.5 + 3.0 + 0.75 55 44 Y

(44) TABLE-US-00019 TABLE 16 Application in Post-Emergence of Saflufenacil, Flumioxazin and Dimethenamid-P binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + dimethenamid-P flumioxazin (B) dimethenamid-P (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT BRAPP 0.5 0.25 55 75.0 5 0.5 + 0.25 + 75.0 75 57 Y

(45) TABLE-US-00020 TABLE 17 Application in Post-Emergence of Saflufenacil, Flumioxazin and Acetochlor binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + acetochlor flumioxazin (B) acetochlor (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AVEFA 1.0 0.25 20 50.0 10 1.0 + 0.25 + 50.0 30 28 Y

(46) TABLE-US-00021 TABLE 18 Application in Post-Emergence of Saflufenacil, Flumioxazin and Pendimethalin binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + pendimethalin flumioxazin (B) pendimethalin (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AVEFA 1.0 0.25 20 150.0 0 1.0 + 0.25 + 150.0 30 20 Y

(47) TABLE-US-00022 TABLE 19 Application in Post-Emergence of Saflufenacil, Flumioxazin and Dicamba binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + dicamba flumioxazin (B) dicamba (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.13 85 4.375 40 0.5 + 0.13 + 4.375 100 91 Y

(48) TABLE-US-00023 TABLE 20 Application in Post-Emergence of Saflufenacil, Flumioxazin and Imazamox binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + imazamox flumioxazin (B) imazamox (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.25 0.13 90 0.125 10 0.25 + 0.13 + 0.125 100 91 Y ECHCG 0.25 0.25 0 0.5 0 0.25 + 0.25 + 0.5 30 0 Y

(49) TABLE-US-00024 TABLE 21 Application in Post-Emergence of Saflufenacil, Flumioxazin and Imazethapyr binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + imazethapyr flumioxazin (B) imazethapyr (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.13 85 0.5 25 0.5 + 0.13 + 0.5 100 89 Y DIGSA 0.25 0.25 0 2.0 20 0.25 + 0.25 + 2.0 65 20 Y

(50) TABLE-US-00025 TABLE 22 Application in Post-Emergence of Saflufenacil, Flumioxazin and Atrazine binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + atrazine flumioxazin (B) atrazine (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.13 85 12.5 25 0.5 + 0.13 + 12.5 100 89 Y BRAPP 0.25 0.25 0 12.5 0 0.25 + 0.25 + 12.5 45 0 Y

(51) TABLE-US-00026 TABLE 23 Application in Post-Emergence of Saflufenacil, Flumioxazin and Diclosulam binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + diclosulam flumioxazin (B) diclosulam (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.25 0.25 0 1.0 20 0.25 + 0.25 + 1.0 70 20 Y

(52) TABLE-US-00027 TABLE 24 Application in Post-Emergence of Saflufenacil, Flumioxazin and Mesotrione binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + mesotrione flumioxazin (B) mesotrione (C) observed % expected % Synergism A B % activity % activity activity activity Y/N AMARE 0.25 0.13 90 0.625 0 0.25 + 0.13 + 0.625 100 90 Y BRAPP 0.25 0.25 0 5.0 35 0.25 + 0.25 + 5.0 60 35 Y

(53) TABLE-US-00028 TABLE 25 Application in Post-Emergence of Saflufenacil, Flumioxazin and Isoxaflutole binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + isoxaflutole flumioxazin (B) isoxaflutole (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.13 85 1.0 85 0.5 + 0.13 + 1.0 100 98 Y BRAPP 0.25 0.25 0 2.0 40 0.25 + 0.25 + 2.0 65 40 Y

(54) TABLE-US-00029 TABLE 26 Application in Post-Emergence of Saflufenacil, Flumioxazin and 2,4-D 2-ethylhexyl ester (here: 2,4-D LV ester) binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + 2,4-D LV ester flumioxazin (B) 2,4-D LV ester (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.13 85 6.25 20 0.5 + 0.13 + 6.25 100 88 Y BRAPP 0.25 0.25 0 6.25 20 0.25 + 0.25 + 6.25 40 20 Y

(55) TABLE-US-00030 TABLE 27 Application in Post-Emergence of Saflufenacil, Flumioxazin and Topramezone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin topramezone flumioxazin (B) topramezone (C) observed % expected % Synergism A B % activity % activity activity activity Y/N Weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.5 0.25 25 0.5 0 0.5 + 0.25 + 0.5 70 25 Y ECHCG 0.5 0.25 25 0.25 20 0.5 + 0.25 + 0.25 55 40 Y BRADC 0.25 0.25 10 0.25 0 0.25 + 0.25 + 0.25 30 10 Y ABUTH 0.25 0.25 85 0.25 0 0.25 + 0.25 + 0.25 95 85 Y

(56) TABLE-US-00031 TABLE 28 Application in Post-Emergence of Saflufenacil, Flumioxazin and Fomesafen binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + fomesafen flumioxazin (B) fomesafen (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.5 95 1.5 5 0.5 + 0.5 + 1.5 100 95 Y AVEFA 0.25 0.5 60 1.5 20 0.25 + 0.5 + 1.5 75 68 Y BRADC 0.25 0.5 75 3.0 30 0.25 + 0.5 + 3.0 90 83 Y

(57) TABLE-US-00032 TABLE 29 Application in Post-Emergence of Saflufenacil, Flumioxazin and Clethodim binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + flumioxazin + clethodim flumioxazin (B) clethodim (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 0.5 95 0.75 5 0.5 + 0.5 + 0.75 100 95 Y

(58) TABLE-US-00033 TABLE 30 Application in Post-Emergence of Saflufenacil, Dicamba and Acetochlor binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + acetochlor dicamba (B) acetochlor (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.25 4.375 20 25.0 25 0.25 + 4.375 + 25.0 60 40 Y BRAPP 0.5 8.75 25 50.0 5 0.5 + 8.75 + 50.0 50 29 Y

(59) TABLE-US-00034 TABLE 31 Application in Post-Emergence of Saflufenacil, Dicamba and Pendimethalin binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + pendimethalin dicamba (B) pendimethalin (C) observed % expected % Synergism A B % activity % activity activity activity Y/N Weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 4.375 30 37.5 0 0.5 + 4.375 + 37.5 60 30 Y ECHCG 0.5 8.75 30 75.0 0 0.5 + 8.75 + 75.0 40 30 Y

(60) TABLE-US-00035 TABLE 32 Application in Post-Emergence of Saflufenacil, Dicamba and Imazethapyr binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + imazethapyr dicamba (B) imazethapyr (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 4.375 30 0.5 0 0.5 + 4.375 + 0.5 75 30 Y

(61) TABLE-US-00036 TABLE 33 Application in Post-Emergence of Saflufenacil, Dicamba and Atrazine binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + atrazine dicamba (B) atrazine (C) observed % expected % Synergism A B % activity % activity activity activity Y/N Weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 4.375 30 12.5 25 0.5 + 4.375 + 12.5 80 48 Y SETVI 0.5 8.75 25 25.0 25 0.5 + 8.75 + 25.0 65 44 Y

(62) TABLE-US-00037 TABLE 34 Application in Post-Emergence of Saflufenacil, Dicamba and Diclosulam binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + diclosulam dicamba (B) diclosulam (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 4.375 30 0.125 10 0.5 + 4.375 + 0.125 75 37 Y BRAPP 0.5 8.75 25 1.0 45 0.5 + 8.75 + 1.0 60 59 Y

(63) TABLE-US-00038 TABLE 35 Application in Post-Emergence of Saflufenacil, Dicamba and Mesotrione binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + mesotrione dicamba (B) mesotrione (C) observed % expected % Synergism A B % activity % activity activity activity Y/N Weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 4.375 30 0.625 75 0.5 + 4.375 + 0.625 90 83 Y BRAPP 0.5 8.75 25 5.0 40 0.5 + 8.75 + 5.0 65 55 Y

(64) TABLE-US-00039 TABLE 36 Application in Post-Emergence of Saflufenacil, Dicamba and Isoxaflutole binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + isoxaflutole dicamba (B) isoxaflutole (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.25 4.375 20 0.5 50 0.25 + 4.375 + 0.5 80 60 Y

(65) TABLE-US-00040 TABLE 37 Application in Post-Emergence of Saflufenacil, Dicamba and Topramezone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + topramezone dicamba (B) topramezone (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.5 8.5 15 0.25 0 0.5 + 8.5 + 0.25 50 15 Y ECHCG 0.5 8.5 35 0.25 25 0.5 + 8.5 + 0.25 55 51 Y AVEFA 0.5 8.5 10 0.25 0 0.5 + 8.5 + 0.25 20 10 Y AMARE 0.25 8.5 95 0.25 40 0.25 + 8.5 + 0.25 100 97 Y ABUTH 0.25 8.5 15 0.25 10 0.25 + 8.5 + 0.25 50 24 Y

(66) TABLE-US-00041 TABLE 38 Application in Post-Emergence of Saflufenacil, Dicamba and Imazamox binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba imazamox dicamba (B) imazamox (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 8.5 0 0.5 15 0.25 + 8.5 + 0.5 70 15 Y DIGSA 0.25 8.5 10 0.5 10 0.25 + 8.5 + 0.5 40 19 Y AMARE 0.25 8.5 95 0.5 40 0.25 + 8.5 + 0.5 100 97 Y ABUTH 0.25 8.5 15 0.5 0 0.25 + 8.5 + 0.5 45 15 Y

(67) TABLE-US-00042 TABLE 39 Application in Post-Emergence of Saflufenacil, Dicamba and Dimethenamid-P binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + dimethenamid-P dicamba (B) dimethenamid-P (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.25 8.5 10 75 80 0.25 + 8.5 + 75 90 82 Y AMARE 0.25 8.5 95 37.5 0 0.25 + 8.5 + 37.5 100 95 Y ABUTH 0.5 8.5 60 37.5 0 0.5 + 8.5 + 37.5 80 60 Y

(68) TABLE-US-00043 TABLE 40 Application in Post-Emergence of Saflufenacil, Dicamba and Fomesafen binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + fomesafen dicamba (B) fomesafen (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 6.0 45 3.0 20 0.5 + 6.0 + 3.0 60 56 Y AMARE 0.5 6.0 95 3.0 65 0.5 + 6.0 + 3.0 100 98 Y DIGSA 0.25 6.0 30 1.5 20 0.25 + 6.0 + 1.5 50 44 Y ECHCG 0.5 6.0 25 1.5 20 0.5 + 6.0 + 1.5 55 40 Y

(69) TABLE-US-00044 TABLE 41 Application in Post-Emergence of Saflufenacil, Dicamba and Clethodim binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + dicamba + clethodim dicamba (B) clethodim (C) observed % expected % Synergism A B % activity % activity activity activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 6.0 45 0.75 5 0.5 + 6.0 + 0.75 55 48 Y AMARE 0.5 6.0 95 0.75 20 0.5 + 6.0 + 0.75 100 96 Y DIGSA 0.25 6.0 30 0.75 0 0.25 + 6.0 + 0.75 40 30 Y